LOXL2 and cancer: LOXL2 associates with and catalyses H3K36ac deacetylation thus blocking H3K36ac-dependent transcription of genes, including MYC proto-oncogene, BHLH transcription factor (MYC), cyclin D1 (CCND1), HIF1A, and CD44, thereby restricting cancer cell proliferation [17].